Sources

7 Total Sources

FDA Clears Takeda's Orzeyful for 120,000 U.S. Narcolepsy Patients as First Orexin-Mimicking Drug

Smithsonian Magazine2d ago

FDA Approves Takeda's Orzeyful, First Drug Targeting Narcolepsy Type 1 Root Cause

FDA Approves Takeda's Orzeyful for Narcolepsy Type 1, Targeting Orexin Pathway

US FDA approves Takeda's sleep disorder pill | Reuters

Yahoo! Voices1d ago

FDA Approves First Drug to Treat a Cause of Narcolepsy

FDA Approves First Drug to Treat a Cause of Narcolepsy - AOL

Medical Daily2d ago

FDA Approves First Narcolepsy Drug That Targets the Brain Signal Loss Behind the Disorder

narcolepsy #sleepmedicine #nt1 | Sleep Medicine Specialists of South Florida